SAGLIO, Giuseppe
SAGLIO, Giuseppe
SCIENZE CLINICHE E BIOLOGICHE
A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia
2019-01-01 Fava, Carmen; Berchialla, Paola; Petiti, Jessica; Bochicchio, Maria Teresa; Izzo, Barbara; Giugliano, Emilia; Ottaviani, Emanuela; Errichiello, Santa; Rege Cambrin, Giovanna; Venturi, Claudia; Luciano, Luigiana; Daraio, Filomena; Calistri, Daniele; Martino, Alessandro; Saglio, Giuseppe; Martinelli, Giovanni; Pane, Fabrizio; Cilloni, Daniela; Gottardi, Enrico Marco
A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS
2015-01-01 Baccarani, M; Castagnetti, F; Gugliotta, G; Breccia, M; Iurlo, A; Levato, L; Abruzzese, E; Stagno, F; Bonifacio, M; Gozzini, A; Pregno, P; Binotto, G; Annunziata, M; Galieni, P; Fava, C; Bocchia, M; Gobbi, M; Russo, D; Specchia, G; Soverini, S; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Rosti, G
A differentiating and apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor
2021-01-01 Stefano Sainas, Paola Circosta, Marta Giorgis, Agnese Chiara Pippione, Marilena Marraudino, Mohammad Houshmand, Brigitta Bonaldo, Valentina Gaidano, Alessandro Cignetti, Stefano Gotti, Giuseppe Saglio, Salam Al-Karadaghi, Donatella Boschi, Marco Lucio Lolli
A differentiating and apoptotic therapy for acute myeloid leukaemia using potent human dihydroorotate dehydrogenase inhibitors.
2019-01-01 Stefano Sainas, Agnese Chiara Pippione, Davide Bonanni, Marta Giorgis, Paola Circosta, Marilena Marraudino, Valentina Gaidano, Alessandro Cignetti, Giuseppe Saglio, Salam Al-Karadaghi, Donatella Boschi, Marco Lucio Lolli
A new non canonical role of IkB-alpha in chronic myleoid leukemia pathogenesis
2013-01-01 S Crivellaro; C Panuzzo; G Carrà; F Crasto; R lorenzatti; F Daraio; F Carnuccio; G Saglio; A Morotti
A new oncogenic role of BCR-ABL/OOF in chronic myeloid leukemia pathogenesis
2013-01-01 C Panuzzo; S Crivellaro; C Casnici; E Cibrario; F Crasto; R Lorenzatti; F Daraio; K Crotta; G Carrà; A Morotti; G saglio; G Volpe
A new pro-apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor
2021-01-01 Sainas Sainas, Paola Circosta, Noemi Villella, Elena Martino, Agnese Chiara Pippione, Mohammad Houshmand, Marta Giorgis, Valentina Gaidano, Alessandro Cignetti, Caterina Peraldo Neia, Giovanna Chiorino, Salam Al-Karadaghi, Donatella Boschi, Giuseppe Saglio, Marco Lucio Lolli.
A Ph-Negative Myeloproliferative Disorder with JAK2 Mutation Disclosed by Imatinib Therapy in Two Patients with Ph+ CML.
2006-01-01 Emilia Giugliano; Dario Ferrero; Carmen Fava; Chiara Dellacasa; Giovanna Mattioli; Patrizia Scaravaglio; Enrico Gottardi; Stefano Ulisciani; Filomena Daraio; Giuseppe Saglio; Giovanna Rege.
A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib.
2012-01-01 Dario Ferrero; Elena Crisà; Marco Cerrano; Mario Boccadoro; Francesca Pirillo; Maura Nicolosi; Umberto Vitolo; Giovanna Rege Cambrin; Carmen Fava; Giuseppe Saglio; Monia Lunghi; Gioacchino Catania; Alessandro Levis; and Patrizia Pregno.
A retrospective real-life analysis of chronic myeloid leukemia patients in suboptimal response to imatinib: three centres experience.
2012-01-01 Ferrero D; Crisà E; Rege-Cambrin G; Fava C; Cerrano M; Pirillo F; Nicolosi M; Boccadoro M; Saglio G; Vitolo U; Pregno P.
A very sensitive and rapid method for BCR-ABL T315Imutation detection by peptide nucleic acid directed PCR clamping
2009-01-01 E. Bracco; M. Spagna; R. Pedrola; V. Rosso; F. Arruga; M. Lo Iacono; S. Carturan; F. Messa; C. Panuzzo; P. Nicoli; E. Messa; A. Rotolo; A. Morotti; S. Mussino; A. Balbo; D. Cilloni; S.G. Saglio
Absence of Spred, a Negative Regulator of Tyrosine Kinase Activity, in Acute Myeloid Leukemia Patients
2012-01-01 Rosso V; Panuzzo C; Bracco E; Carturan S; Campia V; Favole A; Signorino E; Niparuk P; Calabrese C; De Luca L; Caivano A; Morano A; Frassoni F; Saglio G; Cilloni D
Absence of Spred1, a negative regulator of Ras/MAPK pathway, as a mechanism responsible for the constitutive activation of RTK mediated signalling in acute leukemias
2005-01-01 Cilloni D; Bracco E; Defilippi I; Messa F; Carturan S; Di Giovanni D; Arruga F; Rosso V; Catalano R; Messa E; Morotti A; Serra A; Saglio G
Adhesion of polymorphonuclear cells to endothelial cells is physiologically inhibited by Gas6
1998-01-01 M. Gallicchio; C. Dianzani; M. Fontana; F. Capelli; M. Vidali; F. Bottarel; M. Bragardo; N. Surico; G. Garbarino; G. Saglio; U. Dianzani; R. Fantozzi; G.C. Avanzi
Altered erythropoiesis in mouse models of type 3 Hemochromatosis (Hh3)
2014-01-01 F. Riondato; L. Ferbo; R.M. Pellegrino; M. Boero; B. Miniscalco; G. Saglio; M. De Gobbi; A. Roetto.
ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML
2015-01-01 C. Panuzzo, G. Carrà, S. Crivellaro, R. Piazza, U. Familiari, S. Rocca, F. Fusella, G. Saglio, M. Brancaccio, A. Morotti
An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease
2017-01-01 Daraio, F; Giugliano, E; Fava, C; Lorenzatti, R; Varotto, M; Barberio, D; Bernardi, S; Izzo, B; Errichiello, S; Bochicchio, MT; Venturi, C; Albano, F; Saglio, G; Pane, F; Martinelli, G; Specchia, G; Russo, D; Gottardi, EM
ANALYSIS OF IRON METABOLISM IN TFR2 TARGETED ANIMALS BRAIN
2013-01-01 Rosa Maria Pellegrino;Enrica Boda;Martina Boero;Francesca Montarolo;Alessandro Volpengo;Giuseppe Saglio;Annalisa Buffo; Antonella Roetto
Apoptotic and differentiating therapy for AML using potent human dihydroorotate dehydrogenase inhibitor
2021-01-01 Sainas Sainas, Circosta Paola, Pippione Agnese Chiara, Giorgis Marta, Marraudino Marilena, Houshmand Mohammad, Bonaldo Brigitta, Gaidano Valentina, Cignetti Alessandro, Saglio Giuseppe, Al-Karadaghi Salam, Boschi Donatella, Lolli Marco Lolli
Arterial Thrombotic Events in CML Patients Treated with First-Line Nilotinib: Incidence, Management and Impact on the Long Term Outcome - a Gimema CML WP Analysis
2017-01-01 Gugliotta, G; Castagnetti, F; Breccia, M; D'adda, M; Stagno, F; Levato, L; Carella, AM; Martino, B; Tiribelli, M; Fava, C; Gozzini, A; Salvucci, M; Cedrone, M; Trabacchi, E; Usala, E; Scortechini, AR; Luciano, L; Soverini, S; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia | 2019 | Fava, Carmen; Berchialla, Paola; Petiti, Jessica; Bochicchio, Maria Teresa; Izzo, Barbara; Giugliano, Emilia; Ottaviani, Emanuela; Errichiello, Santa; Rege Cambrin, Giovanna; Venturi, Claudia; Luciano, Luigiana; Daraio, Filomena; Calistri, Daniele; Martino, Alessandro; Saglio, Giuseppe; Martinelli, Giovanni; Pane, Fabrizio; Cilloni, Daniela; Gottardi, Enrico Marco | |
| A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS | 2015 | Baccarani, M; Castagnetti, F; Gugliotta, G; Breccia, M; Iurlo, A; Levato, L; Abruzzese, E; Stagno, F; Bonifacio, M; Gozzini, A; Pregno, P; Binotto, G; Annunziata, M; Galieni, P; Fava, C; Bocchia, M; Gobbi, M; Russo, D; Specchia, G; Soverini, S; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Rosti, G | |
| A differentiating and apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor | 2021 | Stefano Sainas, Paola Circosta, Marta Giorgis, Agnese Chiara Pippione, Marilena Marraudino, Mohammad Houshmand, Brigitta Bonaldo, Valentina Gaidano, Alessandro Cignetti, Stefano Gotti, Giuseppe Saglio, Salam Al-Karadaghi, Donatella Boschi, Marco Lucio Lolli | |
| A differentiating and apoptotic therapy for acute myeloid leukaemia using potent human dihydroorotate dehydrogenase inhibitors. | 2019 | Stefano Sainas, Agnese Chiara Pippione, Davide Bonanni, Marta Giorgis, Paola Circosta, Marilena Marraudino, Valentina Gaidano, Alessandro Cignetti, Giuseppe Saglio, Salam Al-Karadaghi, Donatella Boschi, Marco Lucio Lolli | |
| A new non canonical role of IkB-alpha in chronic myleoid leukemia pathogenesis | 2013 | S Crivellaro; C Panuzzo; G Carrà; F Crasto; R lorenzatti; F Daraio; F Carnuccio; G Saglio; A Morotti | |
| A new oncogenic role of BCR-ABL/OOF in chronic myeloid leukemia pathogenesis | 2013 | C Panuzzo; S Crivellaro; C Casnici; E Cibrario; F Crasto; R Lorenzatti; F Daraio; K Crotta; G Carrà; A Morotti; G saglio; G Volpe | |
| A new pro-apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor | 2021 | Sainas Sainas, Paola Circosta, Noemi Villella, Elena Martino, Agnese Chiara Pippione, Mohammad Houshmand, Marta Giorgis, Valentina Gaidano, Alessandro Cignetti, Caterina Peraldo Neia, Giovanna Chiorino, Salam Al-Karadaghi, Donatella Boschi, Giuseppe Saglio, Marco Lucio Lolli. | |
| A Ph-Negative Myeloproliferative Disorder with JAK2 Mutation Disclosed by Imatinib Therapy in Two Patients with Ph+ CML. | 2006 | Emilia Giugliano; Dario Ferrero; Carmen Fava; Chiara Dellacasa; Giovanna Mattioli; Patrizia Scaravaglio; Enrico Gottardi; Stefano Ulisciani; Filomena Daraio; Giuseppe Saglio; Giovanna Rege. | |
| A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib. | 2012 | Dario Ferrero; Elena Crisà; Marco Cerrano; Mario Boccadoro; Francesca Pirillo; Maura Nicolosi; Umberto Vitolo; Giovanna Rege Cambrin; Carmen Fava; Giuseppe Saglio; Monia Lunghi; Gioacchino Catania; Alessandro Levis; and Patrizia Pregno. | |
| A retrospective real-life analysis of chronic myeloid leukemia patients in suboptimal response to imatinib: three centres experience. | 2012 | Ferrero D; Crisà E; Rege-Cambrin G; Fava C; Cerrano M; Pirillo F; Nicolosi M; Boccadoro M; Saglio G; Vitolo U; Pregno P. | |
| A very sensitive and rapid method for BCR-ABL T315Imutation detection by peptide nucleic acid directed PCR clamping | 2009 | E. Bracco; M. Spagna; R. Pedrola; V. Rosso; F. Arruga; M. Lo Iacono; S. Carturan; F. Messa; C. Panuzzo; P. Nicoli; E. Messa; A. Rotolo; A. Morotti; S. Mussino; A. Balbo; D. Cilloni; S.G. Saglio | |
| Absence of Spred, a Negative Regulator of Tyrosine Kinase Activity, in Acute Myeloid Leukemia Patients | 2012 | Rosso V; Panuzzo C; Bracco E; Carturan S; Campia V; Favole A; Signorino E; Niparuk P; Calabrese C; De Luca L; Caivano A; Morano A; Frassoni F; Saglio G; Cilloni D | |
| Absence of Spred1, a negative regulator of Ras/MAPK pathway, as a mechanism responsible for the constitutive activation of RTK mediated signalling in acute leukemias | 2005 | Cilloni D; Bracco E; Defilippi I; Messa F; Carturan S; Di Giovanni D; Arruga F; Rosso V; Catalano R; Messa E; Morotti A; Serra A; Saglio G | |
| Adhesion of polymorphonuclear cells to endothelial cells is physiologically inhibited by Gas6 | 1998 | M. Gallicchio; C. Dianzani; M. Fontana; F. Capelli; M. Vidali; F. Bottarel; M. Bragardo; N. Surico; G. Garbarino; G. Saglio; U. Dianzani; R. Fantozzi; G.C. Avanzi | |
| Altered erythropoiesis in mouse models of type 3 Hemochromatosis (Hh3) | 2014 | F. Riondato; L. Ferbo; R.M. Pellegrino; M. Boero; B. Miniscalco; G. Saglio; M. De Gobbi; A. Roetto. | |
| ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML | 2015 | C. Panuzzo, G. Carrà, S. Crivellaro, R. Piazza, U. Familiari, S. Rocca, F. Fusella, G. Saglio, M. Brancaccio, A. Morotti | |
| An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease | 2017 | Daraio, F; Giugliano, E; Fava, C; Lorenzatti, R; Varotto, M; Barberio, D; Bernardi, S; Izzo, B; Errichiello, S; Bochicchio, MT; Venturi, C; Albano, F; Saglio, G; Pane, F; Martinelli, G; Specchia, G; Russo, D; Gottardi, EM | |
| ANALYSIS OF IRON METABOLISM IN TFR2 TARGETED ANIMALS BRAIN | 2013 | Rosa Maria Pellegrino;Enrica Boda;Martina Boero;Francesca Montarolo;Alessandro Volpengo;Giuseppe Saglio;Annalisa Buffo; Antonella Roetto | |
| Apoptotic and differentiating therapy for AML using potent human dihydroorotate dehydrogenase inhibitor | 2021 | Sainas Sainas, Circosta Paola, Pippione Agnese Chiara, Giorgis Marta, Marraudino Marilena, Houshmand Mohammad, Bonaldo Brigitta, Gaidano Valentina, Cignetti Alessandro, Saglio Giuseppe, Al-Karadaghi Salam, Boschi Donatella, Lolli Marco Lolli | |
| Arterial Thrombotic Events in CML Patients Treated with First-Line Nilotinib: Incidence, Management and Impact on the Long Term Outcome - a Gimema CML WP Analysis | 2017 | Gugliotta, G; Castagnetti, F; Breccia, M; D'adda, M; Stagno, F; Levato, L; Carella, AM; Martino, B; Tiribelli, M; Fava, C; Gozzini, A; Salvucci, M; Cedrone, M; Trabacchi, E; Usala, E; Scortechini, AR; Luciano, L; Soverini, S; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G |